ABOUT CENCORA
Cencora combines core pharmaceutical distribution with innovative business solutions to help our partners across the healthcare spectrum get medications to the patients who need them. Biopharmaceutical companies benefit from the global scale and resources of a company ranked #10 on the Fortune 500, combined with local expertise provided by more than 51,000 team members worldwide. Learn more at www.cencora.com.
Cencora has a proven history of bringing complex, transformative cell and gene therapies (CGTs) to market on a global scale. With end-to-end expertise in global strategies and key local markets, Cencora is ready to deliver strategic guidance along with implementation support across a broad array of functional areas. As a connected partner, Cencora is committed to navigating the patient and treatment journeys together with CGT manufacturers, no matter where they are in development.
CENCORA CELL AND GENE THERAPY EVENTS
ThinkLive Cell and Gene Therapy Virtual Summit 2025
Held May 20 – 21, 2025, this event gathered industry leaders, healthcare experts, and innovators to explore the latest advancements in cell and gene therapy. With over 30 speakers and 11 informative sessions across six tracks, the summit provided a platform for discussing critical topics such as the evolving regulatory landscape, patient support programs, and strategic partnerships aimed at enhancing patient access to therapies. Esteemed speakers shared their insights on the challenges faced by health systems in administering these innovative treatments and the importance of aligning patient services with real patient needs.
Watch On Demand
CELL & GENE THERAPIES
Your therapy can make all the difference. Together, we'll unlock its potential.
CONTACT INFORMATION
Cencora
1 W 1st Ave.
Conshohocken, PA 19428
UNITED STATES
FEATURED INSIGHTS
-
![GettyImages-1404912467 patient, treatment, clinical]( "Tips For Partnering With Health Systems: A Critical Step For CGT Commercialization")
Collaborating with health systems is key to CGT commercialization. Learn how to address operational and financial challenges to ensure processes are scalable and patient access is streamlined.
-
![GettyImages-1094847564-scientists-laboratory-flasks-planning-tablet]( "Essential Strategies For Mastering CMC And Avoiding CRLs For CGTs")
CGT developers face rising regulatory challenges around potency, stability, and process control. Find out how proactive planning, expert guidance, and early FDA engagement are key to avoiding delays.
-
![GettyImages-1072249434-lab-tablet]( "Why CMC Is A Key Sticking Point For CGTs And How To Meet FDA Expectations")
FDA scrutiny of CMC for cell and gene therapies is high. Learn common pitfalls—like issues with potency and comparability—and gain actionable strategies to meet regulatory expectations and reduce risk.
-
![GettyImages-2193956924 supply chain, logistics]( "Navigating Commercial Logistics: Key Considerations For Emerging CGT Manufacturers")
A successful cell and gene therapy launch requires a logistics strategy that keeps patients at the center, plans for disruptions, and prepares for future growth and global expansion.
-
![GettyImages-1089913166 lab]( "Discover The Path To Oncology Success")
The oncology landscape is brimming with innovative therapies and new treatment approaches. Successful commercialization requires a well-orchestrated strategy to bring these complex products to market.
-
![GettyImages-2103894533-office-business-professional-suit-woman-table]( "Optimizing Commercial Distribution As You Prepare To Launch Your CGT")
An effective commercial distribution strategy is crucial for new cell and gene therapies, helping manufacturers navigate challenges and ensure patient access.
-
![GettyImages-1200230502 documents, process, team, office]( "Creating A Compliant And Scalable CGT Logistics Launch Plan")
As cell and gene therapies advance to commercialization, biopharma companies face immense logistical hurdles. A customized, end-to-end strategy is crucial for ensuring product integrity and market success.
EXPLORE OUR THOUGHT LEADERSHIP
Explore the latest insights from the Cencora team.
VIDEOS AND WEBINARS
-
![Cencora CMC struggles in CGT]( "Why Manufacturing And Quality Are Critical To Meeting FDA Expectations")
Why Manufacturing And Quality Are Critical To Meeting FDA ExpectationsCMC failures are a top reason for BLA rejections in cell and gene therapy. Learn proactive strategies to spot subtle quality gaps and ensure your manufacturing aligns with strict FDA expectations.
-
![Cencora - Orchestration]( "Connecting Manufacturers And Providers To The Services Needed For Full End-To-End Patient And Order Management")
Connecting Manufacturers And Providers To The Services Needed For Full End-To-End Patient And Order ManagementStreamline complex cell and gene therapy logistics with an integrated platform that connects manufacturers with vital services, providing full visibility and control for a more efficient and successful patient journey.
-
![Strategic Logistics]( "Crafting Scalable Solutions For Maximum Reach And Success")
Crafting Scalable Solutions For Maximum Reach And SuccessIs your supply chain ready for a blockbuster cell and gene therapy launch? Industry leaders discuss selecting partners, managing risk, and scaling operations for maximum reach and success.
-
![Maximizing Impact]( "Maximizing Impact: Strategies For Building Robust Patient Support Programs")
Maximizing Impact: Strategies For Building Robust Patient Support ProgramsPanelists explore the entire patient journey, from diagnosis to treatment, sharing strategies for creating practical, seamless support systems that ensure access to innovative cell and gene therapies.
-
![Navigating Special Regulatory Pathways For Advanced Therapy Development Success]( "Navigating Special Regulatory Pathways For Advanced Therapy Development Success")
Navigating Special Regulatory Pathways For Advanced Therapy Development SuccessDon't let regulatory hurdles slow you down. Learn from leading experts about special designations like RMAT and PRIME to accelerate your advanced therapy development and ensure success.
BLOGS
-
![GettyImages-1480473800 roadmap]( "Navigating Commercial Logistics For CGTs: A Roadmap To Scalable, Patient-Centered Success")
Navigating Commercial Logistics For CGTs: A Roadmap To Scalable, Patient-Centered SuccessThe commercialization of cell and gene therapies requires a precise and resilient logistics model that can adapt to rapid demand and global expansion while maintaining a patient-first approach.
-
![GettyImages-1323467662 data, meeting, strategy]( "Don't Let Distribution Derail Your CGT Launch")
Don't Let Distribution Derail Your CGT LaunchOvercoming distribution challenges is critical for the success of cell and gene therapies. Learn how to build a flexible, robust strategy to optimize patient access.
-
![GettyImages-657049072 vaccine, pharma]( "Navigating The CGT Supply Chain: Key Logistical Challenges And Solutions")
Navigating The CGT Supply Chain: Key Logistical Challenges And SolutionsCommercializing cell and gene therapies requires overcoming complex logistical hurdles. Customized strategies for temperature control, compliance, and end-to-end delivery are crucial to prevent supply chain issues.
-
![GettyImages-1480558197 Business Corporate Team Meeting]( "Enabling Market Access As CGTs Reach More Patients")
Enabling Market Access As CGTs Reach More PatientsBringing potentially curative cell and gene therapies to more patients requires a focused approach to market access. Discover essential insights into payer dynamics, pricing innovations, and treatment evolution.
-
![GettyImages-1495393006 opthalmology, eye care]( "A Bright Future For Eye Care: The Advanced Therapy Revolution Is Here")
A Bright Future For Eye Care: The Advanced Therapy Revolution Is HereGroundbreaking cell and gene therapies are revolutionizing eye care. Discover how advanced treatments target root causes, offering unprecedented hope for conditions previously deemed untreatable.
